EMERYVILLE, Calif., Dec. 18 ProGenTech Limited, a lifescience and molecular diagnostics company based in Shanghai, China and the SanFrancisco Bay Area has signed a collaboration agreement with the China CDC tocreate a joint laboratory that will focus on developing next generationmolecular diagnostic systems and assays.
Under the terms of the agreement, the joint laboratory will leverageProGenTech's existing Entura instrument platform and proprietary cassettes forthe development of an integrated molecular diagnostic system. This jointsystem will be specifically designed for the rapid surveillance and detectionof existing and emerging pathogens identified by the CDC in China.Development of ProGenTech's first fully-automated systems for samplepreparation was driven by an emphasis on affordability and usability, designconcepts the company plans to carry forward into this joint effort.
Commenting on this new relationship, Dr. XiaoYong Tong of China CDC said,"This collaboration provides the latest molecular diagnostic technology toenhance China CDC's ability in the area of infectious disease detection andprevention."
In October of this year, ProGenTech executed key licenses to enable thedevelopment of several assays for hospital-acquired infection targetsincluding MRSA/MSSA, VRE, and C. difficile. This collaboration with the ChinaCDC will create a unique environment for ProGenTech to rapidly expand itsproduct pipeline by developing infectious disease assays the China CDC sees asthe highest priority.
Dr. Trevor Hawkins, the Chairman and CEO of ProGenTech, added, "Thisrelationship marks an important step forward in our global diagnostics programand gives us a unique partner in the China CDC to lead the world in productsfor rapid infectious disease testing."
ProGenTech currently markets the Entura family of nucleic acidpurification instruments in Asia; however, this collaboration will markProGenTech's first steps towards actively developing and launching diagnosticsproducts in the region. The China-based distributor, Team On S&T Limited, andthe China CDC plan to market and sell the joint products within their networksonce development is completed.
About ProGenTech Limited
ProGenTech Limited is a life science and molecular diagnostics companydeveloping instrumentation for nucleic acid and protein purification andmolecular diagnostics testing. The company was founded in 2005 and hasoffices in the San Francisco Bay Area and Shanghai. ProGenTech's first lineof sample purification instruments, the Entura product family, increasesefficiency in the lab through true walkway automation. These instruments arecompatible with the company's unique cassettes, which allow users to isolate avariety of nucleic acids and proteins from a variety of sample types.ProGenTech is also developing a series of molecular diagnostic assays and afully-integrated instrument for detecting hospital-acquired infection targets.Additional information about ProGenTech can be found athttp://www.progentech.com.
About China CDC
Chinese Center for Disease Control and Prevention (China CDC) has over3000 centers in China, which serve the nation in the area of disease controland prevention. China CDC is a member of the WHO. Additional information aboutChina CDC can be found at http://www.chinacdc.net.cn.
About Team On S&T Limited
Team On is a medical equipment distributor within China with greatinfluence in the life science and molecular diagnostic market. For more infoplease call +86-10-67184281.
SOURCE ProGenTech Limited